To explore this further, pharmaphorum spoke with Emily Harrison, founder and managing director of Nexus Healthcare Education ...
Explore emerging IgA nephropathy therapies—complement and BAFF/APRIL inhibitors, targeted budesonide—and why long‑term safety data still lags. In this episode, Overcoming Access Barriers and Step-Edit ...
Post by Dr. Joseph M. Lucyshyn, University of British Columbia For the past 15 years, the fields of education and psychology have been active in the evidence-based practice (EBP) movement that began ...
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results